Collegium Pharmaceutical, Inc. (COLL) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $636.06M; Treasury Stock, Common, ValueUSD $222.51M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $621.74M; Treasury Stock, Common, ValueUSD $222.51M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $624.95M; Treasury Stock, Common, ValueUSD $222.51M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $41.00K; Additional Paid in CapitalUSD $615.08M; Treasury Stock, Common, ValueUSD $222.51M.
Collegium Pharmaceutical, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Treasury Stock, Carrying Basis USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares, Acquired shares | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $41.00K | $636.06M | $222.51M | $0.00 | $-101.68M | $311.91M | 9.03M | (m) | 3 month · $14.48M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $41.00K | $621.74M | $222.51M | $-219.00K | $-86.63M | $312.42M | 9.03M | (m) | 3 month · $10.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $41.00K | $624.95M | $222.51M | $319.00K | $-101.13M | $301.68M | 9.03M | 12 month · $25.00M | 12 month · $41.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $41.00K | $615.08M | $222.51M | $292.00K | $-118.09M | $274.81M | 9.03M | (m) | 3 month · $9.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $40.00K | $598.94M | $217.51M | $337.00K | $-149.60M | $232.21M | 8.90M | 3 month · $25.00M | 3 month · $10.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $40.00K | $593.24M | $197.50M | $241.00K | $-161.58M | $234.43M | 8.21M | (m) | 3 month · $11.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $40.00K | $590.25M | $197.50M | $55.00K | $-164.00M | $228.84M | 8.21M | 12 month · $60.12M | 12 month · $32.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $40.00K | $582.76M | $172.38M | $393.00K | $-176.53M | $234.28M | 7.39M | (m) | 3 month · $7.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $40.00K | $567.98M | $165.38M | $-182.00K | $-185.87M | $216.58M | 7.21M | 3 month · $35.00M | 3 month · $10.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $39.00K | $565.11M | $137.38M | $-124.00K | $-205.48M | $222.17M | 6.32M | (m) | 3 month · $7.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $38.00K | $565.95M | $137.38M | $14.00K | $-233.19M | $195.43M | 6.32M | 12 month · $75.46M | 12 month · $14.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $38.00K | $545.94M | $101.92M | $-52.00K | $-265.13M | $178.87M | 4.94M | 3 month · $40.00M | 3 month · $7.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $38.00K | $548.49M | $61.92M | $-38.00K | $-285.76M | $200.81M | 3.24M | (m) | 3 month · $7.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $38.00K | $540.39M | $61.92M | (m) | $-298.77M | $179.73M | 3.24M | (m) | 3 month · $6.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $37.00K | $538.07M | $61.92M | (m) | $-281.34M | $194.84M | 3.24M | 12 month · $14.06M | 12 month · $22.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $37.00K | $525.59M | $54.28M | (m) | $-274.14M | $197.19M | 2.82M | 3 month · $6.42M | 3 month · $5.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $37.00K | $520.04M | (m) | (m) | $-274.60M | $197.61M | (m) | (m) | 3 month · $5.69M | $47.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.46M |
| 2022-03-31 | (m) | $36.00K | $513.31M | (m) | (m) | $-269.41M | $196.08M | (m) | (m) | 3 month · $6.13M | $47.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.46M |
| 2021-12-31 | (m) | $36.00K | $502.10M | $42.86M | (m) | $-256.34M | $202.93M | 2.15M | 12 month · $42.86M | 12 month · $24.25M | $42.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.15M |
| 2021-09-30 | (m) | $36.00K | $499.85M | (m) | (m) | $-231.31M | $251.09M | (m) | 3 month · $17.48M 9 month · $17.48M | 3 month · $5.95M | $17.48M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · 859.04K 9 month · 859.04K | 859.04K |
| 2021-06-30 | (m) | $36.00K | $492.38M | (m) | (m) | $-239.35M | $253.07M | (m) | (m) | 3 month · $6.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $35.00K | $482.20M | (m) | (m) | $-312.20M | $170.03M | (m) | (m) | 3 month · $6.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $35.00K | $519.14M | (m) | (m) | $-333.15M | $186.03M | (m) | (m) | 12 month · $21.91M | (m) | $186.03M | (m) | (m) | (m) | 12 month · $44.78M | (m) | (m) | 0.00 |
| 2020-09-30 | (m) | $35.00K | $512.76M | (m) | (m) | $-340.11M | $172.69M | (m) | (m) | 3 month · $5.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $34.00K | $507.12M | (m) | (m) | $-351.39M | $155.77M | (m) | (m) | 3 month · $5.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $34.00K | $500.48M | (m) | (m) | $-359.45M | $141.06M | (m) | (m) | 3 month · $4.95M | (m) | (m) | 3 month · $44.78M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $34.00K | $447.30M | (m) | (m) | $-359.90M | $87.43M | (m) | (m) | 12 month · $16.53M | (m) | $87.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $34.00K | $441.92M | (m) | (m) | $-357.70M | $84.26M | (m) | (m) | 3 month · $4.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $33.00K | $437.38M | (m) | (m) | $-351.59M | $85.82M | (m) | (m) | 3 month · $4.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $33.00K | $433.19M | (m) | (m) | $-346.88M | $86.35M | (m) | (m) | 3 month · $4.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $33.00K | $428.73M | (m) | (m) | $-337.18M | $91.58M | (m) | (m) | 12 month · $13.78M | (m) | $91.58M | (m) | (m) | (m) | (m) | 12 month · $8.04M | (m) | (m) |
| 2018-09-30 | (m) | $33.00K | $417.01M | (m) | (m) | $-346.26M | $70.78M | (m) | (m) | 3 month · $3.93M 9 month · $10.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $33.00K | $412.41M | (m) | (m) | $-329.76M | $82.68M | (m) | (m) | 3 month · $3.53M 6 month · $6.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $33.00K | $407.49M | (m) | (m) | $-316.70M | $90.82M | (m) | (m) | 3 month · $2.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $33.00K | $402.10M | (m) | (m) | $-298.05M | $104.08M | (m) | (m) | 12 month · $7.95M | (m) | $104.08M | (m) | (m) | 12 month · $1.25M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $31.00K | $376.88M | (m) | (m) | $-280.65M | $96.27M | (m) | (m) | 9 month · $5.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $30.00K | $362.87M | (m) | (m) | $-267.38M | $95.51M | (m) | (m) | 6 month · $3.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $29.00K | $360.60M | (m) | (m) | $-246.26M | $114.37M | (m) | (m) | 3 month · $1.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $29.00K | $358.06M | (m) | (m) | $-223.18M | $134.91M | (m) | (m) | 12 month · $5.79M | (m) | $134.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $24.00K | $269.93M | (m) | (m) | $-195.62M | $74.33M | (m) | (m) | 9 month · $4.14M | (m) | (m) | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $24.00K | $267.81M | (m) | (m) | $-169.18M | $98.66M | (m) | (m) | 6 month · $2.50M | (m) | $98.66M | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $24.00K | $266.38M | (m) | (m) | $-144.66M | $121.74M | (m) | (m) | 3 month · $1.10M | (m) | $121.74M | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $21.00K | $214.06M | (m) | (m) | $-129.01M | $85.07M | (m) | (m) | 12 month · $2.21M | (m) | $85.07M | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $20.00K | $213.03M | (m) | (m) | $-119.48M | $93.56M | (m) | (m) | (m) | (m) | (m) | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $20.00K | $212.52M | (m) | (m) | $-110.12M | $102.42M | (m) | (m) | (m) | (m) | (m) | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $1.00K | $20.23M | (m) | (m) | $-105.45M | $-85.22M | (m) | (m) | (m) | (m) | (m) | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $1.00K | $12.41M | (m) | (m) | $-101.75M | $-89.35M | (m) | (m) | 12 month · $22.00K | (m) | $-89.35M | (m) | $3.00K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-68.22M | (m) | (m) | 12 month · $62.00K | (m) | $-68.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-61.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |